Download
https://www.ndtvprofit.com/business/dr-reddys-acquires-australia-based-mayne-pharmas-us-generic-prescription-portfolio?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The agreement involves an upfront payment of $90 million—around Rs 750 crore—and some contingent payments.
Share